TransCon technology platform
Search documents
Ascendis Pharma to Participate in the 2025 Wells Fargo Healthcare Conference
Globenewswire· 2025-08-28 20:01
Group 1 - Ascendis Pharma A/S will participate in a fireside chat at the 2025 Wells Fargo Healthcare Conference on September 3, 2025, at 8:00 a.m. Eastern Time [1] - A live webcast of the presentation will be available on the Ascendis Pharma website, with a replay accessible for 30 days after the event [2] - Ascendis Pharma is a global biopharmaceutical company focused on its innovative TransCon technology platform to develop new therapies addressing unmet medical needs [3] Group 2 - The company is headquartered in Copenhagen, Denmark, and has additional facilities in Europe and the United States [3] - Ascendis Pharma emphasizes its core values of Patients, Science, and Passion in its operations [3]
Ascendis Pharma to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025
GlobeNewswire News Room· 2025-07-31 20:01
Core Viewpoint - Ascendis Pharma A/S will report its second quarter 2025 financial results and provide a business update on August 7, 2025, after U.S. market close, followed by a conference call and live webcast to discuss the results [1]. Company Overview - Ascendis Pharma is a global biopharmaceutical company that utilizes its innovative TransCon technology platform to develop new therapies aimed at addressing unmet medical needs [3]. - The company is headquartered in Copenhagen, Denmark, with additional facilities in Europe and the United States [3]. Event Details - The live webcast for the financial results discussion can be accessed through the company's website, and a replay will be available for 30 days post-event [2].
Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025
Newsfilter· 2025-04-24 20:01
Core Viewpoint - Ascendis Pharma A/S will report its first quarter 2025 financial results and provide a business update on May 1, 2025, after U.S. market close, followed by a conference call and live webcast [1] Company Overview - Ascendis Pharma is a global biopharmaceutical company focused on its innovative TransCon technology platform to develop new therapies addressing unmet medical needs [3] - The company is headquartered in Copenhagen, Denmark, with additional facilities in Europe and the United States [3] Event Details - The live webcast for the financial results will be accessible through a provided link, and a replay will be available for 30 days post-event [2]